marketcap
Facebook
Twitter
Telegram
Report an ErrorQuarterly report 2024-Q3
added 11-14-2024
Vaccinex Balance Sheet 2011-2024 | VCNX
Annual Balance Sheet Vaccinex
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Debt |
-1.36 M | -6.13 M | -8.27 M | -1.39 M | -2.78 M | -5.62 M | -1.37 M | -624 K | - | - | - | - | - |
Long Term Debt |
26 K | 101 K | 175 K | 1.13 M | - | - | 2.81 M | 1.04 M | - | - | - | - | - |
Long Term Debt Current |
146 K | 164 K | 141 K | - | - | - | - | - | - | - | - | - | - |
Total Non Current Liabilities |
- | - | - | 1.13 M | - | - | 3.18 M | 1.73 M | - | - | - | - | - |
Total Current Liabilities |
5.92 M | 2.54 M | 2.26 M | 13.2 M | - | - | - | - | - | - | - | - | - |
Total Liabilities |
5.94 M | 2.78 M | 2.43 M | 14.3 M | 6.88 M | 6.69 M | 7.35 M | 6.17 M | - | - | - | - | - |
Deferred Revenue |
63 K | - | - | - | - | - | 298 K | - | - | - | - | - | - |
Retained Earnings |
-340 M | -320 M | -300 M | - | -249 M | -217 M | -187 M | -169 M | - | - | - | - | - |
Total Assets |
3.63 M | 7.98 M | 9.84 M | 11.7 M | 4.6 M | 22 M | 5.58 M | 2.84 M | - | - | - | - | - |
Cash and Cash Equivalents |
1.54 M | 6.39 M | 8.59 M | 10.6 M | 2.78 M | 5.62 M | 4.18 M | - | - | - | - | - | - |
Book Value |
-2.31 M | 5.19 M | 7.41 M | -2.61 M | -2.27 M | 15.3 M | -1.77 M | -3.33 M | - | - | - | - | - |
Total Shareholders Equity |
-2.31 M | 5.19 M | 7.41 M | -26.6 M | -26.2 M | -8.62 M | -113 M | - | - | - | - | - | - |
All numbers in USD currency
Quarterly Balance Sheet Vaccinex
| 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Long Term Debt |
- | - | 6 K | 26 K | 44 K | 63 K | 82 K | 101 K | 119 K | 138 K | 156 K | 175 K | 1.13 M | 1.13 M | 1.13 M | 1.13 M | 1.13 M | 1.13 M | 1.13 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Non Current Liabilities |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Liabilities |
6.18 M | 5.23 M | 4.71 M | 5.94 M | 6.43 M | 3.51 M | 2.5 M | 2.78 M | 2.29 M | 1.63 M | 1.93 M | 2.43 M | 3.3 M | 6.85 M | 7.9 M | 14.3 M | 14.3 M | 14.3 M | 14.3 M | 6.88 M | 6.88 M | 6.88 M | 6.88 M | 6.69 M | 6.69 M | 6.69 M | 6.69 M | 7.35 M | 7.35 M | 7.35 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Deferred Revenue |
51 K | 12 K | 59 K | 63 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 42 K | 104 K | - | 298 K | - | 298 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Retained Earnings |
-355 M | -349 M | -344 M | -340 M | -337 M | -332 M | -325 M | -320 M | -315 M | -310 M | -304 M | -300 M | -295 M | -290 M | -284 M | -277 M | -277 M | -277 M | -277 M | -249 M | -249 M | -249 M | -249 M | -217 M | -217 M | -217 M | -217 M | -187 M | -187 M | -187 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Assets |
4.85 M | 2.37 M | 7.37 M | 3.63 M | 2.56 M | 3.08 M | 4.9 M | 7.98 M | 8.61 M | 12.6 M | 18.1 M | 9.84 M | 15.2 M | 23.8 M | 30.7 M | 11.7 M | 11.7 M | 11.7 M | 11.7 M | 4.6 M | 4.6 M | 4.6 M | 4.6 M | 22 M | 22 M | 22 M | 22 M | 5.58 M | 5.58 M | 5.58 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Cash and Cash Equivalents |
2.91 M | 233 K | 2.97 M | 1.54 M | 127 K | 1.91 M | 3.32 M | 6.39 M | 7.19 M | 11.4 M | 16.8 M | 8.59 M | 13.7 M | 22.4 M | 29.4 M | 10.6 M | 10.6 M | 10.6 M | 10.6 M | 2.78 M | 2.78 M | 2.78 M | 2.78 M | 5.62 M | 5.62 M | 5.62 M | 5.62 M | 4.18 M | 4.18 M | 4.18 M | - | 1.66 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Book Value |
-1.32 M | -2.86 M | 2.66 M | -2.31 M | -3.87 M | -423 K | 2.4 M | 5.19 M | 6.32 M | 10.9 M | 16.2 M | 7.41 M | 11.9 M | 16.9 M | 22.8 M | -2.61 M | -2.61 M | -2.61 M | -2.61 M | -2.27 M | -2.27 M | -2.27 M | -2.27 M | 15.3 M | 15.3 M | 15.3 M | 15.3 M | -1.77 M | -1.77 M | -1.77 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Shareholders Equity |
-1.32 M | -2.86 M | 2.66 M | -2.31 M | -3.87 M | -423 K | 2.4 M | 5.19 M | 6.32 M | 10.9 M | 16.2 M | 7.41 M | 11.9 M | 16.9 M | 22.8 M | -26.6 M | -26.6 M | -26.6 M | -26.6 M | -26.2 M | -26.2 M | -26.2 M | -26.2 M | -8.62 M | -8.62 M | -8.62 M | -8.62 M | -125 M | -125 M | -125 M | - | -107 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency